Evidence map›Paper›PMID 42405334›Full record

ArticleFrontiers in cell and developmental biology2026

An exploratory analysis of disulfidptosis-related gene signatures in minimal change disease identifies metabolic and immune associations.

Jiahui Li, Quhuan Li, Yue Shen, Chaohong Nie, Jiao Li, Fengxia Zhang

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiahui Li *First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Quhuan Li *Guangdong Engineering Research Center of Low-Carbon Synthetic Biotechnology, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.
Yue Shen *The First Clinical Medical College of Gannan Medical University, Ganzhou, China.
Chaohong NieThe First Clinical Medical College of Gannan Medical University, Ganzhou, China.
Jiao LiThe First Clinical Medical College of Gannan Medical University, Ganzhou, China.
Fengxia ZhangFirst Affiliated Hospital of Gannan Medical University, Ganzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: We aimed to investigate the association between genes related to disulfidptosis-a form of cell death caused by aberrant disulfide stress and cytoskeletal collapse-and the molecular features of minimal change disease (MCD), the leading cause of primary nephrotic syndrome. Methods: Data from the GeneCards and Gene Expression Omnibus (GEO) databases were integrated to systematically analyze disulfidptosis-related genes in MCD. Machine learning approaches-including generalized linear model (GLM), support vector machine (SVM), random forest (RF), and extreme gradient boosting (XGBoost)-pinpointed four hub genes. These genes were used to construct a diagnostic nomogram. Molecular groups were defined by consensus clustering, and pathway alterations were explored through gene set variation analysis and gene set enrichment analyses. Gene expression was validated by immunohistochemistry (IHC) and immunofluorescence (IF). Results: The diagnostic model based on Conclusion: This study indicates a potential link between disulfidptosis-related genes and MCD, and presents an exploratory diagnostic and molecular classification system that requires further validation in larger cohorts.

Indexed as

bioinformaticsdisulfidptosismachine learningminimal change diseasemolecular groups

Identifiers

PMID42405334
PMCPMC13328497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.